---
title: "Hong Kong's Innovative Drug Sector Gains Momentum"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282119136.md"
description: "Hong Kong's innovative drug sector is experiencing significant growth, with companies like Ascletis Pharmaincreasing over 3% and Hansoh Pharmaceuticalrising by more than 2%. Other firms, including WuXi AppTecand Sihuan Pharmaceutical, are also showing upward trends."
datetime: "2026-04-09T01:42:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282119136.md)
  - [en](https://longbridge.com/en/news/282119136.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282119136.md)
---

# Hong Kong's Innovative Drug Sector Gains Momentum

Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends.

### Related Stocks

- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)
- [00460.HK](https://longbridge.com/en/quote/00460.HK.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [159570.CN](https://longbridge.com/en/quote/159570.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [03692.HK](https://longbridge.com/en/quote/03692.HK.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [520500.CN](https://longbridge.com/en/quote/520500.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [01672.HK](https://longbridge.com/en/quote/01672.HK.md)
- [02359.HK](https://longbridge.com/en/quote/02359.HK.md)

## Related News & Research

- [A Look At Hansoh Pharmaceutical Group’s Valuation As XINYUE Gains Third Rare Disease Approval In China](https://longbridge.com/en/news/282920469.md)
- [Assessing Ascletis Pharma (SEHK:1672) Valuation After ASC30_39 Obesity Candidate Advances Toward FDA IND Filing](https://longbridge.com/en/news/283226504.md)
- [20:30 ETAntengene Presents Three Novel Programs at AACR 2026, Highlighting Next-Generation ADC and AnTenGager® TCEs](https://longbridge.com/en/news/283204044.md)
- [Fusen Pharmaceutical Wins China Approval for Glucosamine Osteoarthritis Capsule](https://longbridge.com/en/news/283163403.md)
- [CICC Reaffirms Their Buy Rating on Livzon Pharmaceutical Group (LVZPF)](https://longbridge.com/en/news/282769048.md)